Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vosoritide for Selected Genetic Causes of Short Stature
NCT04219007Phase 2Active, not recruiting
- Start
- Aug 2020
- Primary completion
- Aug 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of vosoritide in short stature. Started Aug 2020; status: active, not recruiting.
02
Drugs
vosoritide
03
Conditions
short stature
Beyond the preview
Go deeper on NCT04219007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04219007.